Cat Burkat, MD, FACS, professor, will represent the UW-Madison Department of Ophthalmology and Visual Sciences on the Minority Ophthalmology Mentoring (MOM) committee. The MOM program is a partnership between the American Academy of Ophthalmology (AAO) and Association …
Amy Pikalek
Women Face Higher Risk of Blindness Than Men
Studies show there is a gender gap in eye disease. Women are more likely than men to suffer from sight-threatening conditions such as age-related macular degeneration (AMD), cataracts, and glaucoma.1 In support of Healthy Vision Month in …
Equal Right to Sight
On March 8th – International Women’s Day – Seva Canada announced the Equal Right to Sight initiative, a new campaign that focuses on equal access to eye care for women and girls. In 1999, Seva …
UW Pioneer Leaves Legacy of Sight
The world has lost one of the pillars of modern vision research and ophthalmic clinical care; Dr. Matthew Dinsdale (Dinny) Davis passed away Monday, March 5, 2018, surrounded by loved ones. He leaves a legacy …
AMBLYOPIA TREATMENT STUDY (ATS20)
Binocular Dig Rush Game Treatment for Amblyopia
AREDS2
Age-Related Eye Disease Study 2 (AREDS2) 10-Year Follow-On Study
Zoster Eye Disease Study (ZEDS)
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Suppressive Valacyclovir for One Year in Immunocompetent Study Participants with an Episode of Dendriform Epithelial Keratitis, Stromal Keratitis, Endothelial Keratitis, and/or Iritis Due to Herpes Zoster Ophthalmicus (HZO) in the Year Prior to Enrollment (ZEDS)
CHROMA
A Phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration.
INTERMITTENT EXOTROPIA STUDY (IXT1)
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia